| UniProt ID | BT2A1_HUMAN | |
|---|---|---|
| UniProt AC | Q7KYR7 | |
| Protein Name | Butyrophilin subfamily 2 member A1 | |
| Gene Name | BTN2A1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 527 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | ||
| Protein Sequence | MESAAALHFSRPASLLLLLLSLCALVSAQFIVVGPTDPILATVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVALVIHNITAQENGTYRCYFQEGRSYDEAILHLVVAGLGSKPLISMRGHEDGGIRLECISRGWYPKPLTVWRDPYGGVAPALKEVSMPDADGLFMVTTAVIIRDKSVRNMSCSINNTLLGQKKESVIFIPESFMPSVSPCAVALPIIVVILMIPIAVCIYWINKLQKEKKILSGEKEFERETREIALKELEKERVQKEEELQVKEKLQEELRWRRTFLHAVDVVLDPDTAHPDLFLSEDRRSVRRCPFRHLGESVPDNPERFDSQPCVLGRESFASGKHYWEVEVENVIEWTVGVCRDSVERKGEVLLIPQNGFWTLEMHKGQYRAVSSPDRILPLKESLCRVGVFLDYEAGDVSFYNMRDRSHIYTCPRSAFSVPVRPFFRLGCEDSPIFICPALTGANGVTVPEEGLTLHRVGTHQSL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Ubiquitination | RPASLLLLLLSLCAL CHHHHHHHHHHHHHH | 4.57 | 27667366 | |
| 46 | N-linked_Glycosylation | ILATVGENTTLRCHL CEEEECCCCEEEEEE | 32.22 | UniProtKB CARBOHYD | |
| 57 | Ubiquitination | RCHLSPEKNAEDMEV EEEECCCCCHHHCCH | 65.91 | - | |
| 79 | Ubiquitination | SPAVFVYKGGRERTE CCEEEEEECCCCCCH | 49.97 | 27667366 | |
| 100 | Phosphorylation | RGRTTFVSKDISRGS CCCCEEEECCCCCCC | 22.03 | - | |
| 101 | Ubiquitination | GRTTFVSKDISRGSV CCCEEEECCCCCCCE | 54.50 | - | |
| 107 | Phosphorylation | SKDISRGSVALVIHN ECCCCCCCEEEEEEE | 11.78 | - | |
| 114 | N-linked_Glycosylation | SVALVIHNITAQENG CEEEEEEEEECCCCC | 23.37 | 19349973 | |
| 120 | N-linked_Glycosylation | HNITAQENGTYRCYF EEEECCCCCEEEEEE | 35.71 | 19349973 | |
| 143 (in isoform 3) | Ubiquitination | - | 10.46 | 21890473 | |
| 147 | Phosphorylation | LVVAGLGSKPLISMR HHHCCCCCCCEEEEC | 35.82 | 24719451 | |
| 173 | Ubiquitination | ISRGWYPKPLTVWRD EECCCCCCCEEEEEC | 36.64 | - | |
| 204 | O-linked_Glycosylation | ADGLFMVTTAVIIRD CCCEEEEEEEEEECC | 9.39 | OGP | |
| 213 | Phosphorylation | AVIIRDKSVRNMSCS EEEECCCCHHCCEEE | 30.51 | 24260401 | |
| 216 | Ubiquitination | IRDKSVRNMSCSINN ECCCCHHCCEEEECC | 25.27 | 29967540 | |
| 222 | Ubiquitination | RNMSCSINNTLLGQK HCCEEEECCCCCCCC | 21.09 | 33845483 | |
| 230 | Ubiquitination | NTLLGQKKESVIFIP CCCCCCCCCEEEECC | 47.54 | - | |
| 232 | Phosphorylation | LLGQKKESVIFIPES CCCCCCCEEEECCHH | 29.41 | 24248375 | |
| 234 | Ubiquitination | GQKKESVIFIPESFM CCCCCEEEECCHHHC | 3.45 | 22817900 | |
| 238 | Ubiquitination | ESVIFIPESFMPSVS CEEEECCHHHCCCCC | 52.36 | 29967540 | |
| 243 | Ubiquitination | IPESFMPSVSPCAVA CCHHHCCCCCHHHHH | 24.36 | 32015554 | |
| 243 | Phosphorylation | IPESFMPSVSPCAVA CCHHHCCCCCHHHHH | 24.36 | 24248375 | |
| 267 | Phosphorylation | IPIAVCIYWINKLQK HHHHHHHHHHHHHHH | 8.63 | 24248375 | |
| 277 | Ubiquitination | NKLQKEKKILSGEKE HHHHHHHHHHCCCCH | 50.39 | 29967540 | |
| 280 (in isoform 1) | Ubiquitination | - | 48.67 | 21890473 | |
| 281 (in isoform 1) | Ubiquitination | - | 46.69 | 21890473 | |
| 283 | Ubiquitination | KKILSGEKEFERETR HHHHCCCCHHHHHHH | 71.83 | 33845483 | |
| 289 | Phosphorylation | EKEFERETREIALKE CCHHHHHHHHHHHHH | 39.56 | 24505115 | |
| 295 | Ubiquitination | ETREIALKELEKERV HHHHHHHHHHHHHHC | 51.75 | 21890473 | |
| 295 | Ubiquitination | ETREIALKELEKERV HHHHHHHHHHHHHHC | 51.75 | 22817900 | |
| 295 (in isoform 2) | Ubiquitination | - | 51.75 | 21890473 | |
| 295 | Ubiquitination | ETREIALKELEKERV HHHHHHHHHHHHHHC | 51.75 | 21890473 | |
| 295 | Ubiquitination | ETREIALKELEKERV HHHHHHHHHHHHHHC | 51.75 | 21890473 | |
| 299 | Ubiquitination | IALKELEKERVQKEE HHHHHHHHHHCHHHH | 64.54 | 29967540 | |
| 304 | Ubiquitination | LEKERVQKEEELQVK HHHHHCHHHHHHHHH | 65.32 | 32015554 | |
| 313 | Ubiquitination | EELQVKEKLQEELRW HHHHHHHHHHHHHHH | 50.15 | - | |
| 344 | Phosphorylation | AHPDLFLSEDRRSVR CCCCCCCCCCCCHHH | 30.07 | - | |
| 417 (in isoform 5) | Phosphorylation | - | 22.89 | 24719451 | |
| 436 | Phosphorylation | GQYRAVSSPDRILPL CCEEECCCCCCEEEC | 24.99 | 28555341 | |
| 439 | Methylation | RAVSSPDRILPLKES EECCCCCCEEECCHH | 35.41 | - | |
| 444 | Ubiquitination | PDRILPLKESLCRVG CCCEEECCHHHEEEE | 43.23 | - | |
| 465 (in isoform 5) | Phosphorylation | - | 19.59 | 24719451 | |
| 478 | Phosphorylation | HIYTCPRSAFSVPVR CEEECCCHHCCCCCC | 20.86 | 24719451 | |
| 523 | Phosphorylation | LTLHRVGTHQSL--- CEEEECCCCCCC--- | 17.55 | 30576142 | |
| 526 | Phosphorylation | HRVGTHQSL------ EECCCCCCC------ | 28.57 | 28355574 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BT2A1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BT2A1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BT2A1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-114 AND ASN-120, AND MASSSPECTROMETRY. | |